 OSAKA, Japan AMSTERDAMBUSINESS WIREShionogi Co., Ltd. and its European subsidiary, Shionogi B.V. hereafter Shionogi, today announces that its innovative antibiotic, cefiderocol, is now available in Norway for the treatment of infections due to aerobic Gram-negative bacteria in adults 18 years or older with limited treatment options.1 Cefiderocol is available to purchase in Norway ...... 